Framework for Equitable Allocation of COVID-19 Vaccine (2020) / Chapter Skim
Currently Skimming:
Appendix A: Study Methods
Appendix A: Study Methods
Pages 217-236
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 217... ...
In addition to conducting a review of the relevant literature, the committee held eight virtual meetings, three of which included open public sessions that incorporated remarks from and discussion between invited stakeholders and experts. Midway through the study process, the committee released Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, which was open for written public comment over the 4-day period September 1–4, 2020.
|
From page 218... ...
The committee heard from stakeholders representing ongoing vaccine initiatives, local and state health department officials, those speaking about ensuring public trust and equity, and experts using statistical modeling to inform vaccine efforts in different scenarios given the innumerable unknowns and variables. PUBLIC COMMENT PERIOD The committee made available a discussion draft of its framework to obtain input from members of the public, especially groups disproportionately affected by COVID-19, to inform the committee's final report.
|
From page 219... ...
The formal public comment period was announced on August 27, 2020, 5 days in advance of posting the discussion draft. The announcement consisted of a comprehensive overview of written and oral comment opportunities3 posted on the study webpage, as well as an e-mail4 sent to listservs maintained by the National Academy of Medicine (NAM)
|
From page 220... ...
NAM president Victor Dzau provided a welcome, and committee co-chairs William Foege and Helene Gayle presented an overview of the committee's process and discussion draft. Next, public commenters representing minority communities, state and local government and health care, health and medical professional organizations, older adults, occupational risk groups, special populations (such as children and homeless individuals)
|
From page 221... ...
This session afforded the committee the opportunity to hear feedback on various components of the discussion draft of the report to ensure multiple perspectives were taken into consideration and that any recommendations would be feasible and actionable on the ground. Slides and a recording of the session are available from the National Academies website.11 A total of 55 people delivered oral comments at the public listening session, which was also attended by a total of 2,432 people.
|
From page 222... ...
The issue of procedural justice is addressed explicitly in Chapter 6 on risk com munications and community engagement. Summary of Comments on the Risk-Based Allocation Criteria • Consider clarifying that while all have equal worth, all individuals do not have equal risk, nor do they pose equal risk to others.
|
From page 223... ...
Committee Response • The committee added additional narrative before the table to clar ify and describe how the committee applied and interpreted the ratings in the table. The committee clarified the M rating, revised several ratings for population groups, and clarified that within each phase, the population groups are of similar priority.
|
From page 224... ...
° First responders – Adopt a formal definition for first responders. ° Comorbid conditions/rare diseases – There is a need for definitional clarity around the difference between significant morbidity versus moderate morbidity and what the impact of multiple comorbid conditions play.
|
From page 225... ...
• Clarify the state flexibility in applying the phases and the practical considerations in transitioning from phase to phase. Committee Response • The committee added language throughout the chapter on the intersectionality considerations.
|
From page 226... ...
Committee Response • The committee added additional language on how it envisions en tities operationalizing the SVI and also added language indicating that entities should use the SVI or another more specific vulner ability index. • The committee proposed one exception to a straightforward pop ulation-based approach to the allocation of vaccine, which would be to withhold a percentage (e.g., 10 percent)
|
From page 227... ...
Committee Response • The committee closely reviewed the many implementation related suggestions as they developed their final report and recommendations. PUBLIC AGENDAS Committee on Equitable Allocation of Vaccine for the Novel Coronavirus First Committee Meeting Public Agenda Friday, July 24, 2020 4:30 p.m.–5:30 p.m.
|
From page 228... ...
Rollins School of Public Health Emory University Helene Gayle, Committee Co-Chair President and Chief Executive Officer The Chicago Community Trust 4:45 p.m. Sponsor Perspective on Charge to the Committee Francis Collins, Sponsor Director National Institutes of Health Butler, Sponsor Jay Deputy Director for Infectious Diseases Centers for Disease Control and Prevention 5:00 p.m.
|
From page 229... ...
Rollins School of Public Health Emory University Helene Gayle, Committee Co-Chair President and Chief Executive Officer The Chicago Community Trust SESSION I Updates from Relevant Ongoing SARS-CoV-2 Vaccine Activities 3:20 p.m. Operation Warp Speed Update: Understanding the SARS CoV-2 Vaccine Development and Procurement Landscape in the United States Moncef Slaoui Chief Advisor Operation Warp Speed 3:30 p.m.
|
From page 230... ...
Discussion with Committee 4:40 p.m. Ensuring Public Trust and Equity in SARS-CoV-2 Vaccine Efforts Monica Schoch-Spana Senior Scholar, Johns Hopkins Center for Health Security Senior Scientist, Department of Environmental Health & Engineering Johns Hopkins Bloomberg School of Public Health Co-Lead and Author, The Public's Role in COVID-19 Vaccination Steven Wakefield Former External Relations Director (Retired)
|
From page 231... ...
Using Infectious Disease Dynamics to Inform Prioritization Efforts Marc Lipsitch Professor of Epidemiology Department of Epidemiology Department of Immunology and Infectious Diseases Director, Center for Communicable Disease Dynamics Harvard T.H. Chan School of Public Health Mokdad Ali Chief Strategy Officer, Population Health Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation, School of Medicine University of Washington 5:40 p.m.
|
From page 232... ...
• from previously identified members of the public for feed Hear back on various components of Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. • Hold an open public comment period between members of the public and members of the committee.
|
From page 233... ...
Montague Cobb/NMA Health Institute Elizabeth Ofili, Association of Black Cardiologists Ellen Provost, Alaska Native Tribal Health Consortium EpiCenter Elena Rios, National Hispanic Medical Association Roberts, Alaska Native Tribal Health Consortium Jim Winston Wong, National Council of Asian Pacific Islander Physicians 12:50 p.m. Public Comment Period: State and Local Government and Health Care Oscar Alleyne, National Association of County & City Health Officials David Gerstner, Dayton (OH)
|
From page 234... ...
Public Comment Period: Occupational Risk Debbie Berkowitz, National Employment Law Project Scott DiMauro, National Education Association/Ohio Education Association Alexis Guild, Farmworker Justice Gary Ludwig, International Association of Fire Chiefs Peter Matz, Food Industry Association Rebecca Reindel, AFL–CIO Mily Trevino-Sauceda, Alianza Nacional de Campesinas Randi Weingarten, American Federation of Teachers 3:20 p.m.
|
From page 235... ...
Open Public Comment Period with the General Public 5:00 p.m. Closing Comments from Co-Chairs and Adjourn Meeting
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.